How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

Abstract excerpt

In past years, a diagnosis of bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic cell transplant (HCT) conferred nearly universal mortality secondary to lack of consensus for diagnostic criteria, poorly understood disease pathogenesis, and very few studies of therapeutic or supportive care interventions. Recently, however, progress has been made in these areas: revised consensus diagnostic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hematopoietic Stem Cell Transplantation
• Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
• Share to Transplantation: Methods and Outcomes